Annual report [Section 13 and 15(d), not S-K Item 405]

INVESTMENTS

v3.25.0.1
INVESTMENTS
12 Months Ended
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]  
INVESTMENTS INVESTMENTS
The Company has interests in 201 partnership or joint venture entities. The limited liability companies and limited partnerships in which the Company is the general partner are generally engaged directly or indirectly in the acquisition, development, operation and ownership of investments in real estate, credit, renewable energy and secondaries. The accounting principles of these entities are substantially the same as those of the Company. Additionally, the Company has direct investments in several funds, including certain Bridge-sponsored funds. The Company’s investments are summarized below (in thousands):
Carrying Value
Investments December 31, 2024 December 31, 2023
Accrued performance allocations(1)
$ 339,560  $ 381,993 
Other investments:
Partnership interests in Company-sponsored funds(2)
153,181  177,718 
Investments in third-party partnerships(3)
15,364  13,917 
Other(4)
12,615  12,026 
Total other investments $ 181,160  $ 203,661 
(1)Represents various investment accounts held by the Bridge GPs for carried interest in Bridge-sponsored funds. There is a disproportionate allocation of returns to the Company as general partner or equivalent based on the extent to which cumulative performance of the fund exceeds minimum return hurdles. Investment is valued using NAV of the respective vehicle, which are based on asset valuations one quarter in arrears for our managed funds or current period NAV for our managed perpetual REITs.
(2)Partnership interests in Company-sponsored funds are valued using the NAV of the respective vehicle.
(3)Investments in limited partnership interests in third-party private property technology venture capital firms are valued using NAV of the respective vehicle.
(4)Other investments are accounted for using the measurement alternative to measure at cost adjusted for any impairment and/or observable price changes.
The Company recognized (loss) income related to its accrued performance allocations and other investments of $(2.9) million, $(138.0) million and $188.7 million for the years ended December 31, 2024, 2023, and 2022, respectively, of which $6.8 million, $(131.6) million, and $184.5 million for years ended December 31, 2024, 2023 and 2022, respectively, related to accrued performance allocations recognized under the equity method.
Of the total accrued performance allocations balance as of December 31, 2024 and 2023, $57.6 million and $55.5 million, respectively, was payable to affiliates and are included in accrued performance allocations compensation in the consolidated balance sheets as of the periods then ended.
The fair value of the accrued performance allocations related to our managed funds is reported on a three-month lag from the fund financial statements due to timing of the information provided by the funds and third-party entities unless information is available on a more timely basis. As a result, any changes in the markets in which our managed funds operate, and the impact market conditions have on underlying asset valuations, may not yet be reflected in reported amounts. The fair value of our managed perpetual REITs are based on the current period NAV.
The Company evaluates each of its equity method investments, excluding accrued performance allocations, to determine if any were significant as defined by the SEC. As of December 31, 2024 and 2023, no individual equity method investment held by the Company met the significance criteria. As a result, the Company is not required to provide separate financial statements for any of its equity method investments.